Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases
Journal of Extracellular Vesicles · 2023-02 · 12 (2)
DOI: 10.1002/jev2.12305 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 12.02.2023. Verfasst von Guoping Li und 28 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Nucleic Acids. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, BLRD VA, NIBIB NIH HHS.
Abstract (Originalsprache)
Extracellular vesicles (EVs) carry diverse bioactive components including nucleic acids, proteins, lipids and metabolites that play versatile roles in intercellular and interorgan communication. The capability to modulate their stability, tissue‐specific targeting and cargo render EVs as promising nanotherapeutics for treating heart, lung, blood and sleep (HLBS) diseases. However, current limitations in large‐scale manufacturing of therapeutic‐grade EVs, and knowledge gaps in EV biogenesis and heterogeneity pose significant challenges in their clinical application as diagnostics or therapeutics for HLBS diseases. To address these challenges, a strategic workshop with multidisciplinary experts in EV biology and U.S. Food and Drug Administration (USFDA) officials was convened by the National Heart, Lung and Blood Institute. The presentations and discussions were focused on summarizing the current state of science and technology for engineering therapeutic EVs for HLBS diseases, identifying critical knowledge gaps and regulatory challenges and suggesting potential solutions to promulgate translation of therapeutic EVs to the clinic. Benchmarks to meet the critical quality attributes set by the USFDA for other cell‐based therapeutics were discussed. Development of novel strategies and approaches for scaling‐up EV production and the quality control/quality analysis (QC/QA) of EV‐based therapeutics were recognized as the necessary milestones for future investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pediatrics, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
- Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Anesthesia and Pain Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts, USA.
- Children's Hospital of Philadelphia, Comprehensive Bone Marrow Failure Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Förderung
- NHLBI NIH HHS
- BLRD VA
- NIBIB NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- NIDA NIH HHS
- NIMH NIH HHS
Zitieren
APA
Li, G., Chen, T., Dahlman, J., Eniola-Adefeso, L., Ghiran, I. C., Kurre, P., Lam, W. A., Lang, J. K., Marbán, E., Martín, P., Momma, S., Moos, M., Nelson, D. J., Raffai, R. L., Ren, X., Sluijter, J. P. G., Stott, S. L., Vunjak-Novakovic, G., Walker, N. D., …, & Sundd, P. (2023). Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases. Journal of Extracellular Vesicles, 12(2). https://doi.org/10.1002/jev2.12305
Vancouver
Li G, Chen T, Dahlman J, Eniola-Adefeso L, Ghiran IC, Kurre P, et al. Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases. Journal of Extracellular Vesicles. 2023;12(2). doi:10.1002/jev2.12305
BibTeX
@article{Li2023,
author = {Li, Guoping and Chen, Tianji and Dahlman, James and Eniola-Adefeso, Lola and Ghiran, Ionita C and Kurre, Peter and Lam, Wilbur A and Lang, Jennifer K and Marbán, Eduardo and Martín, Pilar and Momma, Stefan and Moos, Malcolm and Nelson, Deborah J and Raffai, Robert L and Ren, Xi and Sluijter, Joost P G and Stott, Shannon L and Vunjak-Novakovic, Gordana and Walker, Nykia D and Wang, Zhenjia and Witwer, Kenneth W and Yang, Phillip C and Lundberg, Martha S and Ochocinska, Margaret J and Wong, Renee and Zhou, Guofei and Chan, Stephen Y and Das, Saumya and Sundd, Prithu},
title = {Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases},
journal = {Journal of Extracellular Vesicles},
year = {2023},
volume = {12},
number = {2},
doi = {10.1002/jev2.12305}
}
EUVIMED